Release
📈 Stocks
CSL Seqirus Completes 2026/27 Influenza Vaccine Campaign for U.S. Market
(3 minutes ago)
CSL Seqirus completes its 2026/27 influenza vaccine production cycle, bolstering U.S. supply chains as the company fulfills the bulk of its seasonal…